• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: COVID-19

Effectiveness of COVID boosters in MS: an update

November 30, 2022  

ECTRIMS 2022 HIGHLIGHTS – SATURDAY, OCTOBER 29 EDITION

October 29, 2022  

ECTRIMS 2022 HIGHLIGHTS – THURSDAY, OCTOBER 27 EDITION

October 27, 2022  

Bivalent COVID booster approved in Canada

September 16, 2022  

COVID-19 and MS – updated findings

July 28, 2022  

COVID update: the 7th wave

July 13, 2022  

Key changes in Canadian MS care during the pandemic

July 7, 2022  

Pandemic prescribing – what changed?

July 6, 2022  

EAN 2022 HIGHLIGHTS – THURSDAY, JUNE 30 EDITION

June 30, 2022  

EAN 2022 HIGHLIGHTS – TUESDAY, JUNE 28 EDITION

June 28, 2022  
1
2
3
Next

Browse by Topic

MS (332)
AD (81)
PD (77)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (21)
ECTRIMS 2015 (13)
Library (13)
AAN 2015 (11)
ECTRIMS 2019 (10)
ECTRIMS 2021 (10)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (9)
MS SEQUENCING (9)
ECTRIMS 2013 (9)
AAN 2014 (9)
AAN 2013 (9)
CLINICAL CASES IN MS (8)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (6)
CHARCOT 2013 (6)
AAN 2021 (6)
ECTRIMS 2022 (6)
ECTRIMS 2016 (5)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2022 (5)
NeuroSound (4)
BPD (4)
EAN 2015 (4)
AAN 2020 (3)
PAIN (3)
EAN 2022 (3)
AAN 2017 (3)
ENS 2013 (3)
SPECIAL REPORT (2)
EAN 2020 (2)
NEW DRUGS (2)
SLEEP (2)
APA 2014 (2)
AAN 2018 (2)
hATTR (1)
LUMBAR PUNCTURE (1)
LGS (1)
GUIDELINES (1)
ACTRIMS 2022 (1)
SEIZURE (1)
ALS (1)
EAN 2021 (1)
TSC (1)
APA 2016 (1)
INSOMNIA (1)
AAN 2016 (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
WEST NILE (1)
EAN 2019 (1)
EAN 2016 (0)
ECTRIMS 2020 (0)
View all Topics

Popular Posts

  • CLINICAL CASES IN MS – AN OLDER PATIENT WITH STABLE DISEASE posted on January 10, 2023
  • The end of MS phenotypes? posted on January 26, 2023
  • MS Awards 2022 – Oddities and Observations posted on December 9, 2022
Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions